GlaxoSmithKline Pharmaceuticals Limited — Others, 04-08-2025: Copy of Newspaper Publication

GlaxoSmithKline Pharmaceuticals has released its financial results for the quarter ended June 2025, providing a clear picture of its recent performance. For the quarter, the company reported standalone revenue from operations of ₹804.83 Cr and a net profit after tax of ₹204.70 Cr. Earnings Per Share (EPS) for the period was ₹12.08. These figures, approved by the Board of Directors, are crucial for investors tracking the company's operational strength and profitability, offering transparency into its latest financial health.